Valsartan

• Recalls of blood pressure drug valsartan led to jump in ER visits: study

  Some patients might have avoided taking their medication, due to concerns about a carcinogen, the authors suggest.

  Health

  Nov 12, 2019
  
• Blood-pressure drugs containing Losartan recalled due to potential carcinogen contamination

  Several drugs containing Losartan are being recalled because they may contain impurities that increase the long-term risk of cancer.

  Health

  Mar 11, 2019
  
• Advertisement
• Popular blood pressure drug recalled in the U.S. for cancer-causing impurity

  Aurobindo Pharma has recalled 80 lots of valsartan, a drug used to treat high blood pressure, over probably impurities in pills sold in the U.S.

  Health

  Jan 3, 2019
• Advertisement
• Health Canada bans products from Chinese drug factory tied to blood pressure medication recall

  A Chinese maker of valsartan, an ingredient in recently-recalled blood pressure medications, does not meet manufacturing standards, says Health Canada.

  Health

  Oct 2, 2018
• Second carcinogen found in recalled blood pressure drug: Health Canada

  A second impurity has been found in recalled medications containing valsartan, according to Health Canada.

  Health

  Sep 13, 2018
• Canada expands blood pressure drug recall to include more valsartan medications

  Teva Canada has recalled eight blood pressure drugs containing valsartan, after Health Canada found traces of a cancer-linked impurity in those products.

  Health

  Aug 20, 2018
• Blood pressure medications recalled due to contamination with potential carcinogen

  Many blood pressure and heart attack medications containing valsartan are being recalled due to possible contamination.

  Health

  Jul 10, 2018